Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 25 | $3,389,121 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 11 Mar 2025 17:18 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 07 Mar 2025 | Sale | 6,667 | 21.4394 | 142,936 | I |
| 10 Feb 2025 17:32 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 07 Feb 2025 | Sale | 6,667 | 21.9298 | 146,206 | I |
| 10 Jan 2025 17:31 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 07 Jan 2025 | Sale | 20,260 | 24.1525 | 489,330 | D |
| 10 Jan 2025 17:31 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 07 Jan 2025 | Sale | 1,440 | 24.561 | 35,368 | D |
| 10 Jan 2025 17:31 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 07 Jan 2025 | Sale | 6,577 | 24.1686 | 158,957 | I |
| 10 Jan 2025 17:31 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 07 Jan 2025 | Sale | 90 | 24.6008 | 2,214 | I |
| 22 Oct 2024 16:23 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 18 Oct 2024 | Sale | 716 | 30.0035 | 21,483 | I |
| 16 Jul 2024 17:37 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 16 Jul 2024 | Sale | 1,547 | 25.0111 | 38,692 | I |
| 16 Jul 2024 17:37 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 15 Jul 2024 | Sale | 30,978 | 25.0513 | 776,039 | I |
| 16 Jul 2024 17:37 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 12 Jul 2024 | Sale | 17,475 | 25.0698 | 438,095 | I |
| 10 Jun 2024 18:46 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 06 Jun 2024 | Sale | 1,133 | 20.0551 | 22,722 | D |
| 16 May 2024 19:29 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 14 May 2024 | Sale | 1,107 | 25 | 27,675 | D |
| 13 May 2024 19:35 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 09 May 2024 | Sale | 260 | 25.0596 | 6,515 | D |
| 08 May 2024 20:40 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 06 May 2024 | Sale | 4,875 | 22.7219 | 110,769 | D |
| 15 Apr 2024 19:06 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 11 Apr 2024 | Sale | 17,500 | 25.0342 | 438,098 | D |
| 10 Apr 2024 20:35 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 08 Apr 2024 | Sale | 544 | 19.3979 | 10,552 | D |
| 10 Apr 2024 20:35 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 08 Apr 2024 | Sale | 4,331 | 18.5025 | 80,134 | D |
| 08 Mar 2024 19:52 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 06 Mar 2024 | Sale | 4,875 | 15.6387 | 76,239 | D |
| 08 Feb 2024 20:47 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 06 Feb 2024 | Sale | 4,875 | 15.1094 | 73,658 | D |
| 24 Jan 2024 18:38 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | Chief Operating Officer | 22 Jan 2024 | Sale | 4,875 | 15.135 | 73,783 | D |
| 02 Jan 2024 20:00 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | Chief Operating Officer | 02 Jan 2024 | Sale | 11,000 | 15.0048 | 165,053 | D |
| 02 Jan 2024 20:00 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | Chief Operating Officer | 29 Dec 2023 | Sale | 20 | 15 | 300 | D |
| 02 Jan 2024 20:00 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | Chief Operating Officer | 28 Dec 2023 | Sale | 2,520 | 15.0776 | 37,996 | D |
| 27 Dec 2023 17:28 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | Chief Operating Officer | 26 Dec 2023 | Sale | 102 | 15.005 | 1,531 | D |
| 27 Dec 2023 17:28 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | Chief Operating Officer | 22 Dec 2023 | Sale | 983 | 15.0313 | 14,776 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)